Impact of percutaneous intervention compared to pharmaceutical therapy on complex arrhythmias in patients with chronic total coronary occlusion. Rationale and design of the CTO-ARRHYTHMIA study

Martin Kirk Christensen*, Ashkan Eftekhari, Bent Raungaard, Terje Kristian Steigen, Indulis Kumsaars, Sam Riahi, Peter Søgaard, Leif Thuesen

*Corresponding author for this work

Research output: Contribution to journalJournal articleResearchpeer-review

1 Citation (Scopus)
25 Downloads (Pure)

Abstract

Chronic total coronary occlusions (CTO) occur in up to 50 % of patients with coronary artery disease by angiography. In CTO-patients, clinically significant arrhythmia is potentially important and insufficiently investigated. Therefore, the purpose of the CTO-ARRHYTHMIA study was to investigate the incidence of loop recorder detected clinically significant arrhythmias and the effect on arrhythmias of revascularization by CTO-PCI. The study is an independent sub-study of the NOrdic-Baltic Randomized Registry Study for Evaluation of PCI in Chronic Total Coronary Occlusion (NOBLE-CTO); ClinicalTrials.gov Identifier NCT03392415. NOBLE-CTO prospectively collects procedural data, quality of life measures, echocardiographic and cardiac MRI findings before and after treatment as well as clinical outcomes in all CTO patients that may be treated by PCI.
Original languageEnglish
JournalCardiovascular Revascularization Medicine
Volume54
Pages (from-to)69-72
Number of pages4
ISSN1553-8389
DOIs
Publication statusPublished - Sept 2023

Bibliographical note

Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.

Keywords

  • Arrhythmias
  • CTO
  • Chronic total occlusion
  • Ventricular tachycardia

Fingerprint

Dive into the research topics of 'Impact of percutaneous intervention compared to pharmaceutical therapy on complex arrhythmias in patients with chronic total coronary occlusion. Rationale and design of the CTO-ARRHYTHMIA study'. Together they form a unique fingerprint.

Cite this